Analysis Hofseth Biocare ASA (HOFBF)
6/4/2024
Analysis of Hofseth Biocare ASA (HOFBF)
Hofseth Biocare ASA (HOFBF) has been showing consistent price levels around 0.20210 in the recent days. The Relative Strength Index (RSI) indicator is quite high, indicating overbought conditions at around 70.88. The Moving Average Convergence Divergence (MACD) indicator has been positive, with the MACD line above the signal line and a positive MACD histogram, suggesting a bullish trend.Looking at the Moving Averages (MA), the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating stability in the price trend.
Overall, based on the indicators, HOFBF seems to be in a bullish phase with overbought conditions. Traders and investors may want to monitor the RSI levels for potential corrections and consider other technical and fundamental factors before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The fiscal year ends on September 30, 2023, and the most recent quarter reported is March 31, 2024.
Stock statistics reveal a short ratio of 1.53, with 99.29 million shares shorted out of 15.31 billion float shares. The company has a market capitalization of $2.92 trillion, with 57.59% held by institutions and 5.22% held by insiders.
Valuation metrics show a PEG ratio of 26.32, forward P/E of 26.32, and trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price-to-book ratio of 39.34 and price-to-sales ratio of 7.65.
The stock price summary includes a beta of 1.26, 50-day moving average of $176.26, and 200-day moving average of $181.04. The stock's 52-week low is $164.08, high is $199.62, with a 52-week change of 6.85%.
Dividends and splits information shows a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The company has a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The last split date was on August 31, 2020, with a 4-for-1 split factor. The next dividend date is on May 16, 2024, with an ex-dividend date on May 10, 2024.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in sales from 2020 to 2022, followed by a slight decrease in 2023.
- Overall, there has been a positive revenue growth trend over the past four years, indicating the company's ability to generate increasing sales.
- It is important to further analyze the reasons behind the fluctuations in sales figures to understand the factors driving the company's revenue performance.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 ($162,819,000,000) and the lowest in 2023 ($135,405,000,000).
3. Non-current assets have generally been increasing, with the highest value in 2023 ($217,350,000,000).
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 ($107,147,000,000) and the lowest in 2022 ($50,672,000,000).
6. The company has been relying more on non-current liabilities over the years, as seen in the increasing trend.
7. The company seems to have a stable amount of cash and cash equivalents, with fluctuations in other current assets and short-term investments.
8. Accumulated depreciation has been increasing, indicating aging assets or higher depreciation charges.
9. The company has been investing more in machinery, furniture, and equipment over the years, as seen in the increasing trend of these assets.
10. The company's retained earnings have fluctuated, with negative values in some years, indicating losses or dividend payouts exceeding profits.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. Looking ahead to the next quarter ending on September 30, 2024, analysts project an average EPS of $1.42, ranging from a low estimate of $1.33 to a high estimate of $1.51. This is higher than the EPS of $1.35 reported in the previous year's quarter.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 in the previous fiscal year.
4. Looking further ahead to the next fiscal year ending on September 30, 2025, analysts anticipate an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This shows a potential increase from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, indicating growth in both the short term and the long term.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next year and the next 5 years. The growth rates for the current and next quarter are more moderate in comparison.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average at $204.58. The current price of the security is $192.25, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
MACD of HOFBF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
